InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (19 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
19
T+90 hit rate
59%
T+90 mean return
+8.1%
Across 17 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Dunlop A. Sinclair, Director. Director active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 38 disclosures have been logged. Breakdown: 0 buy · 19 sells. Total volume traded: €15.5m. History available since 18 May 2021. The latest transaction was filed on 1 January 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations38 total
161,567 sharesCommon StockSEC:0001193125-26-224633:0
161,567 sharesCommon StockSEC:0001193125-26-224633
6,267 shares0Common StockSEC:0001127602-25-000419:0
4,600 shares@ US$13.190.5% of flowCommon StockSEC:0001127602-24-024373:0
29,476 shares@ US$36.099.5% of flowCommon StockSEC:0000950170-24-107411:0
7,524 shares@ US$36.792.5% of flowCommon StockSEC:0000950170-24-107411:1
900 shares@ US$13.190.1% of flowCommon StockSEC:0001127602-24-019521:0
35,305 shares@ US$39.2212.8% of flowCommon StockSEC:0000950170-24-076423:0
1,500 shares@ US$13.190.2% of flowCommon StockSEC:0001127602-24-012884:0
18,681 shares@ US$57.1799.7% of flowCommon StockSEC:0000950170-24-034277:0
3,341 shares0Common StockSEC:0001127602-24-000110:0
6,274 shares@ US$13.190.8% of flowCommon StockSEC:0001127602-23-029691:0
24,000 shares@ US$61.13513.3% of flowCommon StockSEC:0000950170-23-068183:0
24,000 shares@ US$49.0011.0% of flowCommon StockSEC:0000899243-23-020450:0
8,894 shares@ US$49.9914.1% of flowCommon StockSEC:0001127602-23-028142:0
500 shares@ US$74.050.3% of flowCommon StockSEC:0001127602-23-012600:0
500 shares@ US$65.330.3% of flowCommon StockSEC:0001127602-23-008357:0
500 shares@ US$52.610.2% of flowCommon StockSEC:0001127602-23-003104:0
500 shares@ US$50.700.2% of flowCommon StockSEC:0001127602-23-001000:0
3,867 shares0Common StockSEC:0000899243-23-000673:0
500 shares@ US$49.930.2% of flowCommon StockSEC:0000899243-22-037440:0
500 shares@ US$60.830.3% of flowCommon StockSEC:0000899243-22-034916:0
15,000 shares@ US$65.009.6% of flowCommon StockSEC:0001127602-22-022205:0
4,306 shares@ US$13.190.6% of flowCommon StockSEC:0001127602-22-021617:0
25,394 shares@ US$14.003.5% of flowCommon StockSEC:0001127602-22-021223:0
25 of 38 declarations
About Dunlop A. Sinclair
Dunlop A. Sinclair is a director at Apellis Pharmaceuticals, Inc.
